Reply to Zamani and Hassanian-Moghaddam, 2017: being specific and targeting disease-causing pathology matter in therapeutics

Affiliations

¹ Department of Pharmacology, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran.
² Student Research Committee, Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
³ Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. Mohammad@TUMS.Ac.Ir.
⁴ Toxicology and Diseases Group, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran. Mohammad@TUMS.Ac.Ir.

Comment

Mohammad Hossein Asghari et al. Arch Toxicol. 2018 May.

. 2018 May;92(5):1907-1908.

doi: 10.1007/s00204-018-2154-7. Epub 2018 Jan 13.

¹ Department of Pharmacology, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran.
² Student Research Committee, Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
³ Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. Mohammad@TUMS.Ac.Ir.
⁴ Toxicology and Diseases Group, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran. Mohammad@TUMS.Ac.Ir.

No abstract available

Comment on

On the mechanisms of melatonin in protection of aluminum phosphide cardiotoxicity.
Asghari MH, Moloudizargari M, Baeeri M, Baghaei A, Rahimifard M, Solgi R, Jafari A, Aminjan HH, Hassani S, Moghadamnia AA, Ostad SN, Abdollahi M. Asghari MH, et al. Arch Toxicol. 2017 Sep;91(9):3109-3120. doi: 10.1007/s00204-017-1998-6. Epub 2017 May 27. Arch Toxicol. 2017. PMID: 28551710
In response to the comments on our recently published paper entitled "on the mechanisms of melatonin in protection of aluminum phosphide cardiotoxicity".
Asghari MH, Moloudizargari M, Abdollahi M. Asghari MH, et al. Arch Toxicol. 2017 Oct;91(10):3457-3458. doi: 10.1007/s00204-017-2029-3. Epub 2017 Jul 21. Arch Toxicol. 2017. PMID: 28733888 No abstract available.
RE: Comment on Asghari et al. 2017: On the mechanisms of melatonin in protection of aluminum phosphide cardiotoxicity.
Zamani N, Hassanian-Moghaddam H. Zamani N, et al. Arch Toxicol. 2018 May;92(5):1905-1906. doi: 10.1007/s00204-017-2136-1. Epub 2017 Dec 18. Arch Toxicol. 2018. PMID: 29255933 No abstract available.